Company / PP&E (Net)
Harmony Biosciences Holdings, Inc. PP&E (Net) History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.3M
FY2024
5-year range
$371.0K / $1.3M
FY2020-FY2024
Trend
+238.8%
vs FY2023
Sector context
#150 of 193
Health Care
What the data says
PP&E (Net) changed +239% YoY in FY2024, a notable deviation from the 5-year average annual change of +26%.
Based on SEC 10-K filings.
$1M in FY2024 with a 5-year CAGR of -1.1%.
Improved from $573,000 to $1M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +15.3%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 193This company $1.3M Sector average $777.6M
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.1%, indicating a declining trend.
- In FY2024, pp&e (net) increased 238.8% year-over-year.
- Ranks #150 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2019.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.3M | +238.8% |
| FY2023 | $371.0K | -35.3% |
| FY2022 | $573.0K | -30.1% |
| FY2021 | $820.0K | -12.6% |
| FY2020 | $938.0K | -29.5% |
| FY2019 | $1.3M | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026